Markets:

Overview

News

Currencies

International

Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

11.63 -0.09 (-0.77%)

Streaming Delayed Price Updated: 9:45 AM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Beta Bionics, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics

January 08, 2026

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026

December 08, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

The Insider Report: The Bears Have Been Poked – Will They Fall Back Asleep? ↗

November 10, 2025

Via Benzinga

Beta Bionics Announces Participation at Upcoming Investor Conferences

November 03, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock ↗

July 30, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

October 29, 2025

The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Beta Bionics (BBNX) Q3 2025 Earnings Transcript ↗

October 29, 2025

Beta Bionics (BBNX) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings Supply Chain

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 29, 2025

Via Benzinga

Wondering what's happening in today's after-hours session? ↗

October 28, 2025

As the regular session of the US market on Tuesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Earnings Scheduled For July 29, 2025 ↗

July 29, 2025

Via Benzinga

Beta Bionics Inc (NASDAQ:BBNX) Tops Q3 2025 Revenue Estimates and Raises Full-Year Guidance ↗

October 28, 2025

Beta Bionics (BBNX) beat Q3 2025 revenue estimates and raised its full-year guidance. The medical device company reported strong user growth and a narrower-than-expected loss.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 28, 2025

Via Benzinga

Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

October 28, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Demystifying Beta Bionics: Insights From 5 Analyst Reviews ↗

October 21, 2025

Via Benzinga

Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025

October 09, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Forecasting The Future: 4 Analyst Projections For Beta Bionics ↗

October 01, 2025

Via Benzinga

Beta Bionics Announces Participation at Upcoming Investor Conferences

August 21, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics (BBNX) Q2 Revenue Soars 54% ↗

July 30, 2025

Via The Motley Fool

Topics Intellectual Property

Beta Bionics BBNX Q2 2025 Earnings Call Transcript ↗

July 30, 2025

Via The Motley Fool

Topics Earnings

Beta Bionics Inc (NASDAQ:BBNX) Surpasses Q2 2025 Estimates and Raises Full-Year Guidance ↗

July 29, 2025

Beta Bionics (BBNX) beats Q2 2025 revenue and EPS estimates, raises full-year guidance. Shares surge 5.7% as iLet Bionic Pancreas and new insulin pump drive growth.

Via Chartmill

Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance

July 29, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns ↗

July 03, 2025

Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 03, 2025

Via Benzinga

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025

July 02, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor

June 19, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗

June 02, 2025

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.

Via Benzinga

Beta Bionics Stock Gains After Mixed Analyst Coverage; Wolfe Bullish, Goldman Neutral ↗

May 30, 2025

Wolfe Research initiated coverage with an ‘Outperform’ rating and a $20 target, while Goldman Sachs started at ‘Neutral’ with a $16 target, citing balanced growth prospects and valuation.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 07, 2025

Via Benzinga

Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025

May 06, 2025

From Beta Bionics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.